DE3853804T2 - Zearalanol-Derivate mit anabolytischer Wirkung. - Google Patents

Zearalanol-Derivate mit anabolytischer Wirkung.

Info

Publication number
DE3853804T2
DE3853804T2 DE3853804T DE3853804T DE3853804T2 DE 3853804 T2 DE3853804 T2 DE 3853804T2 DE 3853804 T DE3853804 T DE 3853804T DE 3853804 T DE3853804 T DE 3853804T DE 3853804 T2 DE3853804 T2 DE 3853804T2
Authority
DE
Germany
Prior art keywords
anabolytic
effect
hydrogen
hydroxyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3853804T
Other languages
English (en)
Other versions
DE3853804D1 (de
Inventor
Martin J Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of DE3853804D1 publication Critical patent/DE3853804D1/de
Publication of DE3853804T2 publication Critical patent/DE3853804T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
DE3853804T 1987-10-13 1988-10-13 Zearalanol-Derivate mit anabolytischer Wirkung. Expired - Fee Related DE3853804T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/108,539 US4849447A (en) 1987-10-13 1987-10-13 Zearalanol derivatives with anabolic activity

Publications (2)

Publication Number Publication Date
DE3853804D1 DE3853804D1 (de) 1995-06-22
DE3853804T2 true DE3853804T2 (de) 1995-11-02

Family

ID=22322783

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853804T Expired - Fee Related DE3853804T2 (de) 1987-10-13 1988-10-13 Zearalanol-Derivate mit anabolytischer Wirkung.

Country Status (6)

Country Link
US (1) US4849447A (de)
EP (1) EP0312353B1 (de)
JP (1) JPH01199960A (de)
AT (1) ATE122669T1 (de)
DE (1) DE3853804T2 (de)
ES (1) ES2072264T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185365A (en) * 1992-06-24 1993-02-09 Cornell Research Foundation, Inc. Insect deterrent azamcrolides
US8067412B2 (en) * 2006-08-11 2011-11-29 Universite De Strasbourg Macrocyclic compounds useful as inhibitors of kinases and HSP90
EA016853B1 (ru) 2006-08-24 2012-08-30 Юниверсити Оф Теннесси Рисерч Фаундейшн Замещенные ациланилиды и их применение
US20110190237A1 (en) * 2008-01-15 2011-08-04 Nexgenix Pharmaceuticals Macrocyclic Prodrug Compounds Useful as Therapeutics
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
IN2015DN01046A (de) 2012-07-13 2015-06-26 Gtx Inc
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3373037A (en) * 1966-06-29 1968-03-12 Commercial Solvents Corp Estrogenic compounds and animal growth promoters
US3453367A (en) * 1966-06-29 1969-07-01 Commercial Solvents Corp Methods for treating inflammation with estrogenic compounds
FR96046E (fr) * 1966-06-29 1972-05-19 Commercial Solvents Corp Composé utilisable comme supplément alimentaire pour les animaux.
FR96016E (fr) * 1966-06-29 1972-05-19 Commercial Solvents Corp Composé utilisable comme supplément alimentaire pour les animaux.
US3887583A (en) * 1968-05-15 1975-06-03 Commercial Solvents Corp Products and process
US3957825A (en) * 1972-04-25 1976-05-18 Commercial Solvents Corporation Process for synthesizing zearalanone and related compounds
US4024602A (en) * 1975-02-10 1977-05-24 Actionite Company, Inc. Apparatus for decasing food links
US4148808A (en) * 1975-08-22 1979-04-10 Int Minerals & Chem Corp Method for reducing zearalenone
US4239772A (en) * 1979-05-30 1980-12-16 International Minerals & Chemical Corp. Allyl and propyl zearalenone derivatives and their use as growth promoting agents
US4443470A (en) * 1981-09-03 1984-04-17 International Minerals & Chemical Corp. Method of promoting growth and enhancing feed efficiency in meat producing animals

Also Published As

Publication number Publication date
ATE122669T1 (de) 1995-06-15
EP0312353A2 (de) 1989-04-19
EP0312353B1 (de) 1995-05-17
JPH01199960A (ja) 1989-08-11
EP0312353A3 (en) 1990-06-20
US4849447A (en) 1989-07-18
DE3853804D1 (de) 1995-06-22
ES2072264T3 (es) 1995-07-16

Similar Documents

Publication Publication Date Title
NO873939D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive retinsyrederivater.
ES2011602T3 (es) Derivados de piridinacarboxamida y su uso como fungicidas.
UA39869C2 (uk) Похідні аспартаму або їх фізіологічно прийнятні солі, спосіб їх отримання та підсолоджувальна композиція
NL300215I1 (nl) Depsipeptide-derivaat, productie daarvan en toepassing daarvan.
ATE223378T1 (de) Prolineamid-derivate
ES2063452T3 (es) Preparacion y uso de esteres y derivados de n-yodopropargil oxicarbonil aminoacido como agentes antimicrobianos.
DE3853804D1 (de) Zearalanol-Derivate mit anabolytischer Wirkung.
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
DE69215694T2 (de) Benzamid-derivate
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
ES2099125T3 (es) Ester alquilico de glutation de tipo oxidado.
FR2681864B1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE69123757T2 (de) Epoxysuccinamidsäurederivat
SE7910391L (sv) Antibakteriella medel
IE873442L (en) Cephalosporin derivative
SE8200679L (sv) 1-bensyl-4-(4-(2-pyrimidinylamino) bensyl 1-2,3-dioxopiperazinderivat, salter derav, forfarande for framstellning derav och karcinostatiska medel der de ingar
ES2096628T3 (es) Derivados heterociclicos.
ES2069881T3 (es) Derivado de 15-desoxiprostaglandina.
ATE53163T1 (de) Desinfektionszusammensetzungen.
ES2038134T3 (es) Composiciones antiemeticas inyectables estables.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee